Jung; Mira

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jung; Mira.The latest application filed is for "dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof".

Company Profile

6.11.20

Jung; Mira - Rockville MD
Jung; Mira - Gaithersburg MD
Jung, Mira - Washington DC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selective histone deacetylase inhibitors for the treatment of human disease Grant 11,407,723 - Grindrod , et al. August 9, 2	2022-08-09
Dual Function Molecules For Histone Deacetylase Inhibition And Ataxia Telangiectasia Mutated Activation And Methods Of Use Thereof App 20220055988 - GRINDROD; Scott ; et al.	2022-02-24
Selective Histone Deacetylase Inhibitors For The Treatment Of Human Disease App 20210261523 - Grindrod; Scott ; et al.	2021-08-26
Selective histone deacetylase inhibitors for the treatment of human disease Grant 11,034,667 - Grindrod , et al. June 15, 2	2021-06-15
Selective Histone Deacetylase Inhibitors For The Treatment Of Human Disease App 20210078963 - Grindrod; Scott ; et al.	2021-03-18
Dual Function Molecules For Histone Deacetylase Inhibition And Ataxia Telangiectasia Mutated Activation And Methods Of Use Thereof App 20200317611 - GRINDROD; Scott ; et al.	2020-10-08
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof Grant 10,745,352 - Grindrod , et al. A	2020-08-18
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof Grant 10,730,834 - Grindrod , et al.	2020-08-04
Selective Histone Deacetylase Inhibitors For The Treatment Of Human Disease App 20200071288 - Grindrod; Scott ; et al.	2020-03-05
Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibi App 20190343859 - Grindrod; Scott ; et al.	2019-11-14
Dual Function Molecules For Histone Deacetylase Inhibition And Ataxia Telangiectasia Mutated Activation And Methods Of Use Thereof App 20180057456 - GRINDROD; Scott ; et al.	2018-03-01
Dual Function Molecules For Histone Deacetylase Inhibition And Ataxia Telangiectasia Mutated Activation And Methods Of Use Thereof App 20180044292 - GRINDROD; Scott ; et al.	2018-02-15
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof Grant 9,809,539 - Grindrod , et al. November 7, 2	2017-11-07
Dual Function Molecules For Histone Deacetylase Inhibition And Ataxia Telangiectasia Mutated Activation And Methods Of Use Thereof App 20160257649 - Grindrod; Scott ; et al.	2016-09-08
Histone deacetylase inhibitors and methods of use thereof Grant 8,748,463 - Kozikowski , et al. June 10, 2	2014-06-10
Isoform selective HDAC inhibitors Grant 8,653,278 - Kozikowski , et al. February 18, 2	2014-02-18
Histone Deacetylase Inhibitors and Methods of Use Thereof App 20130065963 - Kozikowski; Alan P. ; et al.	2013-03-14
Histone deacetylase inhibitors and methods of use thereof Grant 8,222,451 - Kozikowski , et al. July 17, 2	2012-07-17
Histone Deacetylase Inhibitors and Methods of Use Thereof App 20110098504 - Kozikowski; Alan P. ; et al.	2011-04-28
Histone deacetylase inhibitors and methods of use thereof Grant 7,842,835 - Kozikowski , et al. November 30, 2	2010-11-30
Isoform Selective HDAC Inhibitors App 20100196502 - Kozikowski; Alan P. ; et al.	2010-08-05
Delivery system for therapy comprising hollow seeds, and the method of use thereof App 20100143242 - Dritschilo; Anatoly ; et al.	2010-06-10
Delivery system for therapy comprising hollow seed, preferably polymeric App 20060173443 - Dritschilo; Anatoly ; et al.	2006-08-03
Delivery system for therapy comprising hollow seed, the method of use thereof App 20060173442 - Dritschilo; Anatoly ; et al.	2006-08-03
The p65 subunit of nf-kb for the radiosensitization of cells App 20050287158 - Jung, Mira ; et al.	2005-12-29
Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy App 20050222013 - Jung, Mira ; et al.	2005-10-06
Histone deacetylase inhibitors and methods of use thereof App 20050014839 - Kozikowski, Alan P. ; et al.	2005-01-20
Gene therapy for prostate cancer: sensibilization of cells to dna damaging drugs and radiation App 20040067904 - Soldatenkov, Viatcheslav A. ; et al.	2004-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.